Synergistic co-administration of doxorubicin and berberine by PLGA/PVA hybrid polymeric Nanoformulation for breast cancer treatment
Objective(s): The clinical application of doxorubicin (DOX), a potent anticancer agent, is restricted by its serious side-effects and multidrug resistance. The combination strategy of antineoplastic drugs with Berberine (BBR) as plant-derived natural products enhances the cytotoxicity of chemotherap...
Saved in:
| Main Authors: | Masoumeh Rahmani, Mahdieh Hemati, Milad Akhlaghi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2025-04-01
|
| Series: | Nanomedicine Journal |
| Subjects: | |
| Online Access: | https://nmj.mums.ac.ir/article_24749_3c325963ca11c19ea8c5f67cc17e1a8f.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of nanosomal form of doxorubicin, interferon alpha, and nitroglycerin in the threatment of 101.8 glioblastoma in Wistar rats
by: V. V. Kudelkina, et al.
Published: (2022-01-01) -
PLGA – THE SMART POLYMER FOR DRUG DELIVERY
by: N. Surya, et al.
Published: (2021-10-01) -
Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3)
by: Mohammed S. Aleissa, et al.
Published: (2023-01-01) -
Pharmacological properties and therapeutic potential of berberine: a comprehensive review
by: Ke-Qin Fan, et al.
Published: (2025-08-01) -
Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
by: Gui-Feng Tong, et al.
Published: (2017-09-01)